IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 360 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 1.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $716,000 | +6.2% | 15,140 | +35.8% | 0.07% | +84.6% |
| Q4 2019 | $674,000 | -0.1% | 11,150 | -1.1% | 0.04% | +21.9% |
| Q3 2019 | $675,000 | -28.9% | 11,270 | -23.7% | 0.03% | -23.8% |
| Q2 2019 | $950,000 | +24.2% | 14,780 | +56.7% | 0.04% | +40.0% |
| Q1 2019 | $765,000 | -44.4% | 9,430 | -71.4% | 0.03% | -28.6% |
| Q2 2018 | $1,376,000 | -19.7% | 33,010 | -15.0% | 0.04% | -23.6% |
| Q1 2018 | $1,713,000 | -12.3% | 38,855 | 0.0% | 0.06% | -8.3% |
| Q4 2017 | $1,954,000 | -0.8% | 38,855 | 0.0% | 0.06% | -3.2% |
| Q3 2017 | $1,970,000 | +39.4% | 38,855 | +39.9% | 0.06% | +63.2% |
| Q2 2017 | $1,413,000 | – | 27,770 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |